Previous 10 | Next 10 |
home / stock / bhsc:cc / bhsc:cc news
Dr. Brian Cornblatt shared how his misdiagnosis for MS brought him to the nutraceutical industry Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHar...
Dr. Brian Cornblatt will give the keynote address on the "HealthConf" Stage at Collision Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has been invited to one of t...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, En...
Celebrating two years since launch of VINIA® into the US New categories have potential for significant impact on financial results starting in Q1/2024 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQ...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that it has added Dr. John Paul SanGiovanni, world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory boar...
--News Direct-- BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company has released first-quarter 2023 financial numbers that show big gains over 2022. The company saw VINIA revenues growing 209% compared to 1Q 2022, reaching $2.2 million. ...
VINIA® revenues grew 209% compared to Q1 2022 to reach USD 2.2 M Reiterating guidance for year-on-year revenue growth of 3 X to reach USD 17M+ Gross margins continue to improve towards target required to achieve projected cash flow break even in Q4 2023. Reduction in marketing exp...
4.7/5 average rating based on over 2000 verified online customer reviews Over 25,000 new US customers and 50,000+ total orders in last 365 days All 5 "Team VINIA" 2023 NFL draft prospects found NFL teams Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 4, 2023) - ...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable menti...
VINIA will be provided to over 140 NFL athletes preparing for the 2023 NFL Season Five House of Athlete Combine Trainees are heading into the 2023 NFL Draft as members of "Team VINIA" Bioharvest Sciences looks to make an impact by educating athletes and fans on the importance of heart heal...
News, Short Squeeze, Breakout and More Instantly...
Bioharvest Sciences Inc. Company Name:
BHSC:CC Stock Symbol:
CNQC Market:
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 sh...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present a...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), announced today that its board of directors have approved a private placement of up to 697,350 units at a price of USD $7...